Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053555/0467 | |
| Pages: | 7 |
| | Recorded: | 08/19/2020 | | |
| Attorney Dkt #: | G4590-07700US |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 052951 FRAME 0941. ASSIGNOR(S) HEREBY CONFIRMS THE CONFIRMATORY ASSIGNMENT FROM MING-SHI CHANG TO LBL BIOTECHNOLOGY, INC.. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/30/2023
|
Application #:
|
16855637
|
Filing Dt:
|
04/22/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/28/2021
| | | | |
|
Title:
|
COMBINATION THERAPY USING AN IL-20 ANTAGONIST AND AN IMMUNE CHECKPOINT INHIBITOR
|
|
|
Assignee
|
|
|
|
|
| 17TH FLOOR, NO. 932, SEC. 2,YUNG-HUA ROAD |
| AN-PING DIST. |
| TAINAN, TAIWAN |
|
|
Correspondence name and address
|
| |
PROSYLA GROUP PC
|
| |
4275 EXECUTIVE SQUARE, STE. 200
|
| |
LA JOLLA, CA 92037
|
Search Results as of:
06/23/2024 04:31 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
